{"name":"Altacor Ltd.","slug":"altacor-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALT005 Ophthalmic Prep Solution","genericName":"ALT005 Ophthalmic Prep Solution","slug":"alt005-ophthalmic-prep-solution","indication":"Ocular surface disease (indication under investigation)","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Betadine ophthalmic prep solution","genericName":"Betadine ophthalmic prep solution","slug":"betadine-ophthalmic-prep-solution","indication":"Preoperative antiseptic preparation of the ocular surface and periocular skin prior to ophthalmic surgery","status":"phase_3"}]}],"pipeline":[{"name":"ALT005 Ophthalmic Prep Solution","genericName":"ALT005 Ophthalmic Prep Solution","slug":"alt005-ophthalmic-prep-solution","phase":"phase_3","mechanism":"ALT005 is an ophthalmic preparation designed to treat ocular surface disease through topical application to the eye.","indications":["Ocular surface disease (indication under investigation)"],"catalyst":""},{"name":"Betadine ophthalmic prep solution","genericName":"Betadine ophthalmic prep solution","slug":"betadine-ophthalmic-prep-solution","phase":"phase_3","mechanism":"Betadine ophthalmic prep solution is an iodine-based antiseptic that kills microorganisms through oxidative damage to cellular proteins and nucleic acids.","indications":["Preoperative antiseptic preparation of the ocular surface and periocular skin prior to ophthalmic surgery"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQjJBT2tLTnFxTEctUE5ZV19KaUhwa29vb3pOcllRbU1RMlYwVWpWYWJIVjB0elRjTUpHcHQzUjhscGxuRzBKRElIN09IRTlBOWlQMjB1STdkZzhQMldoS2ZuVWxHeWZobkpmU3hteXVLVVJEb09oTjNsQUlkRU02N05NaG1kQ2MwRU1uZ2pyNW81TVdObW43UUNPX0NSMHpvODhpSkd6WXlYeHFnUElzeG1JMzVKZGVWVXVv?oc=5","date":"2026-01-02","type":"deal","source":"pharmaphorum","summary":"Closed & Collaborative H2 2025: Mergers, acquisitions, partnerships, collaborations, and strategic agreements - pharmaphorum","headline":"Closed & Collaborative H2 2025: Mergers, acquisitions, partnerships, collaborations, and strategic agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQejAzNXlMZGhkYmF0YTkwY1I0Qm9hZVdHaWM5NWNzQ3psdUEzNVk3ZFVRWGNnTFQzbzVjWC1wUXNaX20xUXRIVUdDTUZXMWxtQlc1SklfaGJFeVc1N3IyQjNwNjdfNzFOM2drWnRaajZka1V2STJHb2FTbHh1b1I0cTVodWdjU2pvTU53?oc=5","date":"2025-09-08","type":"deal","source":"Association of Optometrists (AOP)","summary":"Altacor is acquired by Fidia Farmaceutici - Association of Optometrists (AOP)","headline":"Altacor is acquired by Fidia Farmaceutici - Association of Optometrists (AOP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxONWgzRVJoc2FEZjlCbmtYX1BrN19OU1h0MWpNOHpaSVl1c0tiNFgxMDUySDVpd1plT21pWXJ5NUEzN09JdnJ1NXhzWWpXZS1uMG9zSVl1RTFkU3BVazhHVnU5R1lxejl4WG0yWjJwV1NEdGRzdVNhSEJPOUg2R0MxMVo0RVJsZzhU?oc=5","date":"2025-09-03","type":"pipeline","source":"Manufacturing Chemist","summary":"Fidia Farmaceutici enters the UK market with the acquisition of Altacor - Manufacturing Chemist","headline":"Fidia Farmaceutici enters the UK market with the acquisition of Altacor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPb052UFJ4OFI3VktadjVsNGh1UGJ6d1ZIdnVhZ3VQclV2UmtlMVc3UjJmbzYtQlVmZUtrV3g1dWpiWmhaTFFYRXl6cXJBc05mMmcyZDdzbzhqUUktUUlnQUhXOVZ2a25qeXVReW5VUDJHd1dRYWhRVG80MUNaTWpfSlZmd2FrQnRNZHoxUEtvSUthUWNSdG9ZOXh3eWhJQjlqLTIxRFQxc2dwa2s0cDZQb010ZmNCUHc2RERVVUo2RmprVGQ5Tk4w?oc=5","date":"2025-09-03","type":"pipeline","source":"Investors in Healthcare","summary":"UK: Fidia Farmaceutici enters UK market with acquisition of Altacor - Investors in Healthcare","headline":"UK: Fidia Farmaceutici enters UK market with acquisition of Altacor","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}